With New LDL Goalposts in FH, Combo Therapy Must Start Early

It’s time to stop futzing about with single LDL-lowering drugs for high- and very-high-risk patients, says lipid expert Kausik Ray.

Related Keywords

Australia , Melbourne , Victoria , Mannheim , Baden Wüberg , Germany , Ireland , Italy , Monash , South Australia , Spain , United Kingdom , Portugal , Denmark , Stephen Nicholls , Kausik Ray , European Society Of Cardiology , Dmsc University Of Copenhagen , Md Imperial College London , Phd Monash University , European Atherosclerosis Society , Imperial College London , European Society , Monash University ,